C. Maliszewski et al., “Cytokine Receptors and B Cell Functions,” The Journal of Immunology, vol. 144, No. 8 (Apr. 15, 1990), pp. 3028-3033. |
H. Renz et al., “Inhibition of Allergen-Induced and Allergen-Specific IgE and IgG1 Production by Soluble IL-4 Receptor (sIL-4R),” The Journal of Allergy and Clinical Immunology, vol. 91, No. 1(2) (Jan. 1993), p. 234. |
W. Fanslow et al., “Soluble Forms of CD40 Inhibit Biologic Responses of Human B Cells,” The Journal of Immunology, vol. 149, No. 2 (Jul. 15, 1992), pp. 655-660. |
M. Ogata et al., PNAS, 86:4215-4219, Jun. 1989. |
D. Maher et al., Prog Growth Factor Res., 3(1):43-56, 1991. |
Knutsen et al., “Asp fl CD4+ Th2-like T-cell Lines in Allergic Bronchopulmonary Asperigillosis”, J. Allergy Clin. Immunol., 94(2):215-221 (1994). |
Clerici et al., “A Th1→Th2 Switch is a Critical Step in the Etiology of HIV Infection”, Immunology Today, 14(3):107-111 (1993). |
Robinson et al., “Predominant TH2-like Bronchoalveolar T-lymphocyte Population In Atopic Asthma”, New England J. of Medicine, 326(5):298-304 (1992). |
Ying et al., “T Lymphocytes and Mast Cells Express Messenger RNA for Interleukin-4 in the Nasal Mucosa in Allergen-induced Rhinitis”, Immunology, 82:200-206 (1994). |
Maggi et al., “Accumulation of Th-2-Like Helper T Cells in the Conjunctiva of Patients with Vernal Conjunctivitis”, J. Immunology, 146(4):1169-1174 (1991). |
Robinson et al., “Activation of CD4+ T cells, increased TH2-type Cytokine mRNA Expression, and Eosinophil Recruitment in Bronchoalveolar Lavage After Allergen Inhalation Challenge in Patients With Atopic Asthma”, J. Allergy Clin. Immunol., 92(2):313-324 (1993). |
van Reijsen et al., “Skin-derived Aeroallergen-specific T-cell Clones of Th2 Phenotype in Patients With Atopic Dermatitis”, J. Allergy Clin Immunol., 90(2);184-193 (1992). |
Millner et al., Abstract of “Soluble IL-4R (sIL-4R) Down Regulates Allergen Specific Lymphocyte Functions in Most Sever Atopic Dermatitis”, American Academy of Allergy and Immunology, Abstract Serial No. 13815 (1994). |
Renz et al., Abstract of “Aerosolized Soluble IL-4R (sIL-4R) Prevents Development of Immediate Hypersensitivity Responses in the Mouse”, Experimental Biology 94 (1993). |
Enssle et al., “Regulation of Interleukin-4 Activity by Soluble Interleukin-4 Receptors”, J. Clin. Lab. Analysis, 9:450-455 (1995). |
Enders et al., Abstract of “Recombinant Soluble Interleukin-4 Receptor Inhibits Allergen Induced Murine Asthma Bronchiale”, 9th Int. Congress of Immunology (1995). |
Gessner “Recombinant Soluble Interkeukin-4 (IL-4) Receptor Acts as an Antagonis of IL-4 in Murine Cutaneous Leishmaniasis”, Infection and Immunity, 62(10):4112-4117 (1994). |
Puccetti et al. “Cure of Murine Candidiasis by Recombinant Soluble Interleukin-4 Receptor”, J. Infectious Diseases, 169:1325-1331 (1994). |
Schorlemmer et al., “Immunoregulation by Recombinant Interkeukin-4 Receptor (IL-4-R) of Murine GvH and SLE-like diseases in BDF1 Hybrid Mice and MRL/lpr Autoimmune Mice”, Agents Actions 41:C180-C182 (1994). |
Schorlemmer et al., “Modulation of the Immunoglobulin Dysregulation in GvH- and SLE-like Diseases by the Murine IL-4 Receptor (IL-4-R)”, Inflamm. Res. 44(2):S194-S196 (1995). |
Kung et al., “Characterization of a Murine Model of Allergic Pulmonary Inflammation”, Int. Arch. Allergy Immunol., 105:83-90 (1994). |
Phillip Scott, J. Immunol., 147(9):3149-3155, Nov. 1, 1991. |
C. DelPrete et al., Allergie et Immunologie, 23(6):239-243, 1991. |
Lennette et al., editors, Manual of Clinical Microbiology, 2nd Edition, Jan. 1, 1974, p. 550-556, 611-616. |
Beeson et al., editors, Textbook of Medicine, 15th Edition, Jan. 1, 1979, pp. 546-547, 630-631, 583-587. |
Mosmann et al., “Diversity of Cytokine Synthesis and Function of Mouse CD4+T Cells”, Immunological Reviews, 123:209-229(1991). |
Sergio romagnani, “Human TH1 and TH2 subsets: doubt no more”, Immunology Today, 12(8):256-257 (1991). |
Else and Grencis, “Helper T-Cell Subsets in Mouse Trichuriasis”, Parasitology Today, 7(11):313-316 (1991). |
“Parasites and Human T-cell Subsets ”, Parasitology Today, 7(10):261 (1991). |
Kapsenberg et al., “Functional Subsets of Allergen-Reactive Human CD4+T cells”, Immunology Today 12(11):392-395 (1991). |
Idzerda et al., “Human Interleukin 4 Receptor Confers Biological Responsiveness and Defines a Novel Receptor Superfamily”, J. Exp. Med. 171:861-873 (1990). |
Dower et al., “Retention of Ligand Binding Activity by the Extracellular Domain of the IL-1 Receptor”, The Journal of Immunology, 142:4314-4320 (1989). |
Mosley et al., “The Murine Interleukin-4 Receptor: Molecular Cloning and Characterization of Secreted and Membrane Bound Forms”, Cell 59:335-348 (1989). |
Zettlmeissl et al., “Expression and Characterization of Human CD4: Immunoglobulin Fusion Proteins”, DNA and Cell Biology 9(5):347-353 (1990). |
Luigina Romani et al., “Neutralizing Antibody to Interleukin 4 Induces Systemic Protection and T Helper Type 1-associated Immunity in Murine Candidiasis”, J. Exp. Med., vol. 176, pp. 19-25, Jul. 1992. |
Luigina Romani et al., “Th1 and Th2 Cytokine Secretion Patterns in Murine Candidiasis: Association of Th1 Responses with Acquired Resistance”, Infection and Immunity, vol. 59, No. 12, pp. 4647-4654, Dec. 1991. |
Michael Sadick et al., “Cure of Murine Leishmaniasis with Anti-Interleukin 4 Monoclonal Antibody”, J. Exp. Med., vol. 171, pp. 115-127, Jan. 1990. |
René Chatelain et al., “IL-4 Induces A Th2 Responses in Leishmania major-Infected Mice”, The Journal of Immunology, vol. 148, No. 4, pp. 1182-1187, Feb. 15, 1992. |
Fred Finkelman et al., “Regulation of Murine in vivo IgG and IgE Responses by a Monoclonal anti-IL-4 Receptor Antibody”, International Immunology, vol. 3, No. 6, pp. 599-607, 1991. |
A. Sher et al., “Regulation of Immunity to Parasites by T Cells and T Cell-Derived Cytokines”, Annu. Rev. Immunol., 10:385-409, 1992. |